Dr Twinfago

Dr Twinfago sells prescription and non-prescription twin-lens eyeglasses and sunglasses engineered for people with heterophoria and mild strabismus. Frames are injection-molded stainless steel or plant-based acetate; lenses are stock 1.56 or custom 1.61 index with prism correction ground in, priced USD 89–189 online. The brand is DTC-only through drtwinfago.com, shipping from Ohio to North America and the EU with virtual try-on and at-home prism tests. The company’s USP is the “Twin-Prism” hinge: each temple hides a micro-adjustable prism slider that lets wearers dial 0–4 Δ diopters of horizontal compensation without changing lenses. Every frame is FDA-listed as a Class I medical device and ships with a pocket prism gauge so users can re-tune after eye fatigue. The best-selling model, Atlas Clear, accounts for 38 % of 2024 sales and is TikTok-noted for relieving screen-induced double vision within minutes. Core buyers are 18-34 digital workers who experience eyestrain, gamers who notice ghosting, and fashion-conscious students told by optometrists they “don’t need full prism yet.” They value medical-grade relief without insurance copays or thick lenses, and they post before/after convergence videos that drive 60 % of site traffic. Sustainability and minimalist tech aesthetics outweigh luxury branding for this cohort. Dr Twinfago competes in the narrow gap between drugstore reading glasses and $400-plus prescription prism eyewear sold by optometry chains. It differentiates through sub-$200 pricing, user-adjustable prism, and medical-device positioning rather than fashion licensing or celebrity endorsements, capturing shoppers who want a clinical fix wrapped in Scandinavian-neutral styling.